IGC Pharma, Inc. (IGC)
0.298
+0.01
(+2.48%)
USD |
NYAM |
Dec 09, 16:00
0.2982
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Free Cash Flow: -6.262M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Esperion Therapeutics, Inc. | -124.49M |
| Theravance Biopharma, Inc. | 243.48M |
| NRX Pharmaceuticals, Inc. | -11.86M |
| CEL-SCI Corp. | -17.36M |
| AIM ImmunoTech, Inc. | -13.33M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.09M |
| Cash from Investing (Quarterly) | -0.374M |
| Cash from Financing (Quarterly) | 3.11M |
| Free Cash Flow Per Share (Quarterly) | -0.0267 |
| Free Cash Flow to Equity (Quarterly) | -2.361M |
| Free Cash Flow to Firm (Quarterly) | -2.416M |
| Free Cash Flow Yield | -25.32% |